The International Journal of Tuberculosis and Lung Disease

HIV/AIDS: the long haul ahead [Editorial]
pp. 1347-1348(2)
Author: Harries, Anthony D.

Coordination of clinical and public health services to improve treatment outcome in low-incidence areas: a role for the TB case manager [Editorial]
pp. 1349-1349(1)
Author: Veen, Jaap

Plagiarism policy of the International Journal of Tuberculosis and Lung Disease [Editorial]
pp. 1350-1350(1)
Authors: Beyers, Nulda; Enarson, Donald A.; Pierard, Clare; Chan-Yeung, Moira

Commentary on the English translation of the Löwenstein (Loewenstein) and Jensen papers [Editorial]
pp. 1351-1351(1)
Author: Kam, Kai Man

Preventive chemotherapy. Where has it got us? Where to go next? [State of the art series. Tuberculosis. Edited by I. D. Rusen. Number 2 in the series]
pp. 1352-1364(13)
Authors: Landry, J.; Menzies, D.

Organisation of a tuberculosis prevalence survey [Educational series: prevalence surveys. Serialised guidelines. Assessing tuberculosis prevalence through population-based surveys. Number 4 in the series]
pp. 1365-1369(5)
Authors: van Leth, F.; Cobelens, F. G.; Onozaki, I.

Management of HIV-infected patients with MDR- and XDR-TB in resource-limited settings [Unresolved issues]
pp. 1370-1375(6)
Authors: Scano, F.; Vitoria, M.; Burman, W.; Harries, A. D.; Gilks, C. F.; Havlir, D.

Consensus statement on the revised World Health Organization recommendations for BCG vaccination in HIV-infected infants: Submitted on behalf of the BCG Working Group, Child Lung Health Section, International Union Against Tuberculosis and Lung Disease, 38th Union World Conference on Lung Health, Cape Town, 8–12 November 2007 [Official statement]
pp. 1376-1379(4)
Authors: Hesseling, A. C.; Cotton, M. F.; Fordham von Reyn, C.; Graham, S. M.; Gie, R. P.; Hussey, G. D.

Culture of tubercle bacilli from blood [Founders of our knowledge]
pp. 1380-1381(2)
Author: Loewenstein, E.

Culture and type differentiation among strains of tubercle bacilli: a simplification of the methodology for application in laboratory practice [Founders of our knowledge]
pp. 1382-1392(11)
Author: Jensen, K. A.

Incidence and risk factors for tuberculosis in HIV-positive subjects by HAART status
pp. 1393-1400(8)
Authors: Moreno, S.; Jarrin, I.; Iribarren, J. A.; Perez-Elías, M. J.; Viciana, P.; Parra, J.; Gomez-Sirvent, J. L.; Lopez-Aldeguer, J.; Gutierrez, F.; Blanco, J. R.; Vidal, F.; Leal, M.; Rodríguez Arenas, M. A.; del Amo, J.; CoRIS-MD

Age-specific cut-offs for the tuberculin skin test to detect latent tuberculosis in BCG-vaccinated children
pp. 1401-1406(6)
Authors: Chan, P-C.; Chang, L-Y.; Wu, Y-C.; Lu, C-Yi; Kuo, H-S.; Lee, C-Y.; Huang, L-M.; Chen, C-J.

Two-step tuberculin skin test and booster phenomenon prevalence among Brazilian medical students
pp. 1407-1413(7)
Authors: Teixeira, E. G.; Kritski, A.; Ruffino-Netto, A.; Steffen, R.; Lapa e Silva, J. R.; Belo, M.; Luiz, R. R.; Menzies, D.; Trajman, A.

Cost-effectiveness of a new interferon-based blood assay, QuantiFERON®-TB Gold, in screening tuberculosis contacts
pp. 1414-1424(11)
Authors: Marra, F.; Marra, C. A.; Sadatsafavi, M.; Morán-Mendoza, O.; Cook, V.; Elwood, R. K.; Morshed, M.; Brunham, R. C.; FitzGerald, J. M.

Tuberculosis in socio-economically deprived neighborhoods: missed opportunities for prevention
pp. 1425-1430(6)
Authors: Lopez De Fede, A.; Stewart, J. E.; Harris, M. J.; Mayfield-Smith, K.

Increasing tuberculosis case detection through intensive referral and tracing in Hunan, China
pp. 1431-1435(5)
Authors: Bai, L. Q.; Yang, H. L.; Jian, X. W.; He, X. G.; Chen, Y. F.; Tang, Y.; Cheng, S. M.; Xiao, S. Y.

Reducing the string test intra-gastric downtime for detection of Mycobacterium tuberculosis
pp. 1436-1440(5)
Authors: Bae, W. H.; Salas, A.; Brady, M. F.; Coronel, J.; Colombo, C. G. L.; Castro, B.; Gilman, R. H.; Moore, D. A. J.

Predicting tuberculosis treatment outcome in a low-incidence area
pp. 1441-1448(8)
Authors: Baussano, I.; Pivetta, E.; Vizzini, L.; Abbona, F.; Bugiani, M.

Drug susceptibility testing of Mycobacterium tuberculosis against second-line drugs using the Bactec MGIT 960 System
pp. 1449-1455(7)
Authors: Rodrigues, C.; Jani, J.; Shenai, S.; Thakkar, P.; Siddiqi, S.; Mehta, A.

Evaluation of new GenoType^® MTBDRplus for detection of resistance in cultures and direct specimens of Mycobacterium tuberculosis
pp. 1456-1460(5)
Authors: Causse, M.; Ruiz, P.; Gutierrez, J. B.; Zerolo, J.; Casal, M.

A bibliometric analysis of tuberculosis research indexed in PubMed, 1997–2006
pp. 1461-1468(8)
Authors: Ramos, J. M.; Padilla, S.; Masiá, M.; Gutiérrez, F.

Transmission of Mycobacterium pinnipedii to humans in a zoo with marine mammals
pp. 1469-1473(5)
Authors: Kiers, A.; Klarenbeek, A.; Mendelts, B.; Van Soolingen, D.; Koëter, G.

Meta- and pooled analyses of the effect of glutathione S-transferase M1 and T1 deficiency on chronic obstructive pulmonary disease
pp. 1474-1481(8)
Authors: Hu, G.; Yao, W.; Zhou, Y.; Hu, J.; Shi, Z.; Li, B.; Ran, P.

Rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis by the direct thin-layer agar method [Short communication]
pp. 1482-1484(3)
Authors: Robledo, J.; Mejia, G. I.; Paniagua, L.; Martin, A.; Guzmán, A.

Polymorphism in CC-chemokine ligand 2 associated with tuberculosis in Zambia [Short communication]
pp. 1485-1488(4)
Authors: Buijtels, P. C. A. M.; van de Sande, W. W. J.; Parkinson, S.; Petit, P. L. C.; van der Sande, M. A. B.; van Soolingen, D.; Verbrugh, H. A.; van Belkum, A.